Quick Answer
Bausch Health Companies Inc. reported Stockholders Equity of -$554.00 million for the year ending 2025.
- Bausch Health Companies Inc. showed an increase of +56.7% in Stockholders Equity from 2024 to 2025.
- This data is from Bausch Health Companies Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $4.01 billion | Q1 2012: $4.08 billion | Q2 2012: $3.70 billion | Q3 2012: $3.79 billion | Q1 2013: $3.59 billion | Q2 2013: $5.70 billion | Q3 2013: $4.95 billion | Q1 2014: $5.09 billion | Q2 2014: $5.26 billion | Q3 2014: $5.12 billion | Q1 2015: $6.45 billion | Q2 2015: $6.44 billion | Q3 2015: $6.34 billion | Q1 2016: $5.66 billion | Q2 2016: $5.30 billion | Q3 2016: $4.17 billion | Q1 2017: $3.89 billion | Q2 2017: $3.93 billion | Q3 2017: $5.33 billion | Q1 2018: $4.54 billion | Q2 2018: $3.47 billion | Q3 2018: $3.15 billion | Q1 2019: $2.69 billion | Q2 2019: $2.60 billion | Q3 2019: $2.48 billion | Q1 2020: $719.00 million | Q2 2020: $474.00 million | Q3 2020: $587.00 million | Q1 2021: -$197.00 million | Q2 2021: -$687.00 million | Q3 2021: -$204.00 million | Q1 2022: -$216.00 million | Q2 2022: -$693.00 million | Q3 2022: -$525.00 million | Q1 2023: -$800.00 million | Q2 2023: -$663.00 million | Q3 2023: -$1.18 billion | Q1 2024: -$1.12 billion | Q2 2024: -$1.18 billion | Q3 2024: -$1.17 billion | Q1 2025: -$1.18 billion | Q2 2025: -$764.00 million | Q3 2025: -$565.00 million.
- Over the full 17 years of available data (2009 to 2025), Bausch Health Companies Inc.'s Stockholders Equity has declined by 140.9%.
- Historical annual values: Fiscal year 2025: -$554.00 million | Fiscal year 2024: -$1.28 billion | Fiscal year 2023: -$1.02 billion | Fiscal year 2022: -$692.00 million | Fiscal year 2021: -$106.00 million | Fiscal year 2020: $535.00 million | Fiscal year 2019: $1.06 billion | Fiscal year 2018: $2.73 billion | Fiscal year 2017: $5.85 billion | Fiscal year 2016: $3.15 billion | Fiscal year 2015: $5.91 billion | Fiscal year 2014: $5.28 billion | Fiscal year 2013: $5.12 billion | Fiscal year 2012: $3.72 billion | Fiscal year 2011: $3.93 billion | Fiscal year 2010: $4.91 billion | Fiscal year 2009: $1.35 billion.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: